Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Total revenues	$ 48,502	$ 29,078	$ 81,206	$ 55,045
Costs and expenses:
Cost of sales	5,543	2,947	9,191	5,753
Research and development	42,308	30,194	79,281	158,858
Selling, general, and administrative	45,947	36,415	85,034	70,797
Total costs and expenses	93,798	69,556	173,506	235,408
Loss from operations	(45,296)	(40,478)	(92,300)	(180,363)
Other income (expense):
Other income (expense), net	1,576	302	932	824
Gain on settlement of forward contract		8,900		8,900
Interest expense	(5,817)	(4,603)	(11,226)	(9,358)
Interest income	3,242	4,097	6,881	7,143
Total other (expense), net	(999)	8,696	(3,413)	7,509
Loss before income taxes	(46,295)	(31,782)	(95,713)	(172,854)
Provision for income taxes	337	479	417	779
Net loss	(46,632)	(32,261)	(96,130)	(173,633)
Accrued dividends on convertible preferred stock	(1,349)	(1,302)	(2,671)	(1,302)
Net loss attributable to common stockholders	$ (47,981)	$ (33,563)	$ (98,801)	$ (174,935)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.75)	$ (0.55)	$ (1.56)	$ (2.89)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.75)	$ (0.55)	$ (1.56)	$ (2.89)
Weighted-average common shares outstanding, basic (in shares)	63,684,359	61,011,824	63,373,489	60,577,691
Weighted-average common shares outstanding, diluted (in shares)	63,684,359	61,011,824	63,373,489	60,577,691
Other comprehensive loss:
Net loss attributable to common stockholders	$ (47,981)	$ (33,563)	$ (98,801)	$ (174,935)
Foreign currency translation adjustment	(2,104)	(302)	(2,106)	(373)
Unrealized (loss), net on marketable securities	(93)	(134)	(103)	(378)
Comprehensive loss	(50,178)	(33,999)	(101,010)	(175,686)
Product revenue, net
Total revenues	$ 48,502	$ 29,078	86,220	$ 55,045
License revenue
Total revenues			$ (5,014)